images (2)

Does this face look like we are laughing with the world _ before these drugs women have been classified as all kinds of sex things so news of a drug like this makes it impossible for us to be happy. Happy for what we are tempted to ask? that someone remembered our dry and dusted libido’s 10 decades later?

If you ask me women get along pretty well with faking ooohs and aaaahhhhhs when the reason is evident, but sincerely if men can get their way with being high like kytes as and when they desire _ hell yes bring the pill please!

What is your take, imagine a man on Viagra and a woman on FLIBANSERIN??? Just the name _ the woman may just kill the man, let’s pretend we didn’t hear this news !

NPR reports below 

The Food and Drug Administration approved the first drug designed to increase a woman’s libido.

The controversial decision was hailed by some doctors and advocates as a long-sought victory for women’s health, but was condemned by others as irresponsible and dangerous.

The little pink pill, known generically as flibanserin, will be sold under the brand name Addyi beginning Oct. 17, according to its maker, Sprout Pharmaceuticals. The medicine is to be taken daily to treat premenopausal women suffering from hypoactive sexual desire disorder, which is essentially a sudden, unexplained loss of any desire to have sex.

“Addyi is a game changer, in my opinion, for women’s health,” said Cynthia Whitehead, Sprout’s CEO. “For decades, millions of women have been waiting for a medical solution to restore their sexual desire. And I’m thrilled that today the decision is finally being turned over to women and their health care providers regarding their sexual health.”

The pill has long history of controversy. The company and its supporters had essentially accused the FDA of being sexist for rejecting the drug twice before while approving Viagra and other drugs to help men with their sexual problems.

“For far too long we’ve reduced all things in the bedroom for men to biology, as witnessed by countless treatment options, and we’ve reduced all things for women to psychology,” Whitehead says.